Pharmacokinetics, Safety, and Efficacy of Gadopiclenol in Pediatric Patients Aged 2 to 17 Years

OBJECTIVES: The aim of this study was to evaluate the pharmacokinetic (PK) profile, safety, and efficacy of gadopiclenol, a new high-relaxivity gadolinium-based contrast agent, in children aged 2 to 17 years. MATERIALS AND METHODS: Children scheduled to undergo contrast-enhanced magnetic resonance i...

Descripción completa

Detalles Bibliográficos
Autores principales: Jurkiewicz, Elżbieta, Tsvetkova, Silvia, Grinberg, Anna, Pasquiers, Blaise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390233/
https://www.ncbi.nlm.nih.gov/pubmed/35318970
http://dx.doi.org/10.1097/RLI.0000000000000865

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390233/
https://www.ncbi.nlm.nih.gov/pubmed/35318970
http://dx.doi.org/10.1097/RLI.0000000000000865

Ejemplares similares